The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size

Nature Communications

Volumn 6, Issue , 2015, Pages

  Watt, K I ^a,c   Turner, B J ^c   Hagg, A ^a   Zhang, X ^b,c   Davey, J R ^a   Qian, H ^a   Beyer, C ^a   Winbanks, C E ^a   Harvey, K F ^b,c   Gregorevic, P ^a,c,d,e  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; MESSENGER RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TEAD; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; HIPPO PROTEIN, MOUSE; PHOSPHOPROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; YAP PROTEIN, MOUSE;

APOPTOSIS; INJURY; MUSCLE; PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL SIZE; CONTROLLED STUDY; FEMALE; FETUS; HEREDITARY MOTOR SENSORY NEUROPATHY; HIPPO PATHWAY; HISTOLOGY; IMMUNOFLUORESCENCE; IN VIVO STUDY; MALE; MOTOR NERVE; MOUSE; MUSCLE CONTRACTION; MUSCLE DENERVATION; MUSCLE HYPERTROPHY; MUSCLE MASS; NERVE DEGENERATION; NERVE INJURY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; UPREGULATION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DENERVATION; GENETICS; HEK293 CELL LINE; HUMAN; HYPERTROPHY; METABOLISM; MUSCLE ATROPHY; ORGAN SIZE; PATHOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BLOTTING, WESTERN; DENERVATION; FEMALE; HEK293 CELLS; HUMANS; HYPERTROPHY; MALE; MICE, INBRED C57BL; MUSCLE FIBERS, SKELETAL; MUSCULAR ATROPHY; NERVE DEGENERATION; ORGAN SIZE; PHOSPHOPROTEINS; PROTEIN-SERINE-THREONINE KINASES; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 84923104694     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7048     Document Type: Article

References (45)

1. Harvey, K. & Tapon, N. The Salvador-Warts-Hippo pathway-an emerging tumour-suppressor network. Nat. Rev. Cancer 7, 182-191 (2007).
2. Zhao, B., Tumaneng, K. & Guan, K. L. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat. Cell Biol. 13, 877-883 (2011).
3. Zhao, B. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761 (2007).
4. Dupont, S. et al. Role of YAP/TAZ in mechanotransduction. Nature 474, 179-183 (2011).
5. Aragona, M. et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154, 1047-1059 (2013).
6. Yu, F. X. et al. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Cell 150, 780-791 (2012).
7. Koontz, L. M. et al. The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev. Cell 25, 388-401 (2013).
8. Camargo, F. D. et al. YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054-2060 (2007).
9. Dong, J. et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133 (2007).
10. Cai, J. et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev. 24, 2383-2388 (2010).
11. Schlegelmilch, K. et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144, 782-795 (2011).
12. Zhang, H., Pasolli, H. A. & Fuchs, E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc. Natl Acad. Sci. USA 108, 2270-2275 (2011).
13. Xin, M. et al. Regulation of insulin-like growth factor signaling by yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 4, ra70 (2011).
14. von Gise, A. et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc. Natl Acad. Sci. USA 109, 2394-2399 (2012).
15. Xin, M. et al. Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl Acad. Sci. USA 110, 13839-13844 (2013).
16. Heallen, T. et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332, 458-461 (2011).
17. Heallen, T. et al. Hippo signaling impedes adult heart regeneration. Development 140, 4683-4690 (2013).
18. Matsui, Y. et al. Lats2 is a negative regulator of myocyte size in the heart. Circ. Res. 103, 1309-1318 (2008).
19. Del Re, D. P. et al. Yes-associated protein isoform 1 (Yap1) promotes cardiomyocyte survival and growth to protect against myocardial ischemic injury. J. Biol. Chem. 288, 3977-3988 (2013).
20. Wei, B. et al. MST1, a key player, in enhancing fast skeletal muscle atrophy. BMC Biol. 11, 12 (2013).
21. Watt, K. I. et al. Yap is a novel regulator of C2C12 myogenesis. Biochem. Biophys. Res. Commun. 393, 619-624 (2010).
22. Judson, R. N. et al. The Hippo pathway member Yap plays a key role in influencing fate decisions in muscle satellite cells. J. Cell Sci. 125, 6009-6019 (2012).
23. Lian, I. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 24, 1106-1118 (2010).
24. Schiaffino, S., Dyar, K. A., Ciciliot, S., Blaauw, B. & Sandri, M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 280, 4294-4314 (2013).
25. Goodman, C. A. et al. Novel insights into the regulation of skeletal muscle protein synthesis as revealed by a new nonradioactive in vivo technique. FASEB J. 25, 1028-1039 (2011).
26. Sartori, R. et al. BMP signaling controls muscle mass. Nat. Genet. 45, 1309-1318 (2013).
27. Bonaldo, P. & Sandri, M. Cellular and molecular mechanisms of muscle atrophy. Dis. Model Mech. 6, 25-39 (2013).
28. Bodine, S. C. et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708 (2001).
29. Komuro, A., Nagai, M., Navin, N. E. & Sudol, M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J. Biol. Chem. 278, 33334-33341 (2003).
30. Zhao, B. et al. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev. 22, 1962-1971 (2008).
31. Judson, R. N. et al. Constitutive expression of Yes-associated protein (Yap) in adult skeletal muscle fibres induces muscle atrophy and myopathy. PLoS ONE 8, e59622 (2013).
32. Quy, P. N., Kuma, A., Pierre, P. & Mizushima, N. Proteasome-dependent activation of mammalian target of rapamycin complex 1 (mTORC1) is essential for autophagy suppression and muscle remodeling following denervation. J. Biol. Chem. 288, 1125-1134 (2013).
33. Yu, F. X. et al. Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation. Genes Dev. 27, 1223-1232 (2012).
34. Shi, L., Fu, A. K. & Ip, N. Y. Molecular mechanisms underlying maturation and maintenance of the vertebrate neuromuscular junction. Trends Neurosci. 35, 441-453 (2012).
35. Hornberger, T. A. Mechanotransduction and the regulation of mTORC1 signaling in skeletal muscle. Int. J. Biochem. Cell. Biol. 43, 1267-1276 (2011).
36. Burkholder, T. J. Mechanotransduction in skeletal muscle. Front. Biosci. 12, 174-191 (2007).
37. Tremblay, A. M. et al. The Hippo transducer YAP1 transforms activated satellite cells and is a potent effector of embryonal rhabdomyosarcoma formation. Cancer Cell 26, 273-287 (2014).
38. Gee, S. T., Milgram, S. L., Kramer, K. L., Conlon, F. L. & Moody, S. A. Yes-associated protein 65 (YAP) expands neural progenitors and regulates Pax3 expression in the neural plate border zone. PLoS ONE 6, e20309 (2011).
39. Jackson, J. R. et al. Satellite cell depletion does not inhibit adult skeletal muscle regrowth following unloading-induced atrophy. Am. J. Physiol. Cell Physiol. 303, C854-C861 (2012).
40. McCarthy, J. J. et al. Effective fiber hypertrophy in satellite cell-depleted skeletal muscle. Development 138, 3657-3666 (2011).
41. Gordon, B. S., Kelleher, A. R. & Kimball, S. R. Regulation of muscle protein synthesis and the effects of catabolic states. Int. J. Biochem. Cell Biol. 45, 2147-2157 (2013).
42. Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257 (2013).
43. Dobrowolny, G. et al. Skeletal muscle is a primary target of SOD1G93Amediated toxicity. Cell Metab. 8, 425-436 (2008).
44. Dupuis, L. & Echaniz-Laguna, A. Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments. Curr. Drug Targets 11, 1250-1261 (2010).
45. Winbanks, C. E. et al. The bone morphogenetic protein axis is a positive regulator of skeletal muscle mass. J. Cell Biol. 203, 345-357 (2013).